• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,517.60 157.59
( 0.21%)
Global Indices
Nasdaq
51,596.42 888.35
(1.75%)
Dow Jones
7,607.58 32.90
(0.43%)
Hang Seng
67,369.16 -1,032.97
(-1.51%)
Nikkei 225
10,347.89 15.59
(0.15%)
Forex
USD-INR
95.72 0.48
(0.51%)
EUR-INR
111.14 0.31
(0.28%)
GBP-INR
128.64 0.40
(0.31%)
JPY-INR
0.60 0.00
(0.43%)

EQUITY - MARKET SCREENER

Consecutive Commodities Limited
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
539091
INE187R01029
1.2547612
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
6.41
17.46
EPS(TTM)
Face Value()
Div & Yield %
0.17
1
0
 

gtl ltd
Glaxosmithkline appoints Vinay Subramanian as Commercial Head – Oncology
Apr 21,2026
Glaxosmithkline Pharmaceuticals announced that Vinay Subramanian, Commercial Head – Oncology would be part of leadership team effective 20 April 2026 based out of Mumbai, and he would be part of senior Management Personnel of the Company effective the said date.

Vinay brings with him over 24 years of experience in the Pharmaceuticals, Life Science. Healthcare Devices, and Medical Technology sectors. Prior to joining GSK. he served as the India Enabling leader - Enterprise & Neighboring Countries at Roche Products India Pvt ltd. where he was responsible for the immunotherapy portfolio and was part of their leadership team.